Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bakos

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Behavioural Pharmacology|September 23, 2003
Stress, social avoidance and anxiolytics: a potential model of stress-induced anxietyJ Haller, Cs Leveleki, J Baranyi, et al.
Allergy|June 26, 2003
High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticariaN Bakos, B Fekete, Z Prohászka, et al.
The European Journal of Neuroscience|October 31, 2002
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxietyJ Haller, N Bakos, M Szirmay, et al.
The British Journal of Dermatology|May 22, 2018
Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension studyF Valenzuela, N J Korman, R Bissonnette, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Behavioural Pharmacology|September 23, 2003
Stress, social avoidance and anxiolytics: a potential model of stress-induced anxietyJ Haller, Cs Leveleki, J Baranyi, et al.
Allergy|June 26, 2003
High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticariaN Bakos, B Fekete, Z Prohászka, et al.
The European Journal of Neuroscience|October 31, 2002
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxietyJ Haller, N Bakos, M Szirmay, et al.
The British Journal of Dermatology|May 22, 2018
Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension studyF Valenzuela, N J Korman, R Bissonnette, et al.
Pageof 2